{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:51Z","timestamp":1793146611927,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T00:00:00Z","timestamp":1473292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["CSD2010-00045"],"award-info":[{"award-number":["CSD2010-00045"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2012-39852"],"award-info":[{"award-number":["SAF2012-39852"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/03035,"],"award-info":[{"award-number":["PI11\/03035,"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/02425"],"award-info":[{"award-number":["PI11\/02425"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01561"],"award-info":[{"award-number":["PI14\/01561"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["2014-2610"],"award-info":[{"award-number":["2014-2610"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12035-016-0088-8","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T02:09:23Z","timestamp":1473300563000},"page":"5550-5562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer\u2019s Disease: Potential and Limitations"],"prefix":"10.1007","volume":"54","author":[{"given":"Marta","family":"Cos\u00edn-Tom\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Antonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Llad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ezquerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Pall\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Sanchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-1206","authenticated-orcid":false,"given":"Coral","family":"Sanfeliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Kaliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,8]]},"reference":[{"issue":"3","key":"88_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.wad.0000184005.22611.cc","volume":"19","author":"JC Morris","year":"2005","unstructured":"Morris JC (2005) Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 19(3):163\u2013165","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"88_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA et al. (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):280\u2013292","journal-title":"Alzheimers Dement"},{"issue":"5","key":"88_CR3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jalz.2016.01.009","volume":"12","author":"JL Molinuevo","year":"2016","unstructured":"Molinuevo JL et al. (2016) Ethical challenges in preclinical Alzheimer\u2019s disease observational studies and trials: results of the Barcelona summit. Alzheimers Dement 12(5):614\u2013622","journal-title":"Alzheimers Dement"},{"issue":"3","key":"88_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois B et al. (2016) Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 12(3):292\u2013323","journal-title":"Alzheimers Dement"},{"issue":"228","key":"88_CR5","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","volume":"6","author":"RA Sperling","year":"2014","unstructured":"Sperling RA et al. (2014) The A4 study: stopping AD before symptoms begin? Sci Transl Med 6(228):228fs13","journal-title":"Sci Transl Med"},{"key":"88_CR6","unstructured":"Cheng, L., et al. (2014) Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20(10):1188\u20131196"},{"issue":"12","key":"88_CR7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.18632\/aging.100624","volume":"5","author":"KS Sheinerman","year":"2013","unstructured":"Sheinerman KS et al. (2013) Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging (Albany NY) 5(12):925\u2013938","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"88_CR8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S et al. (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med 13(11):1359\u20131362","journal-title":"Nat Med"},{"issue":"1","key":"88_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9(1):119\u2013128","journal-title":"Lancet Neurol"},{"issue":"2","key":"88_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr et al. (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2):207\u2013216","journal-title":"Lancet Neurol"},{"issue":"3","key":"88_CR11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O et al. (2006) Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5(3):228\u2013234","journal-title":"Lancet Neurol"},{"issue":"4","key":"88_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL et al. (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12(4):357\u2013367","journal-title":"Lancet Neurol"},{"issue":"4","key":"88_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3988\/jcn.2009.5.4.153","volume":"5","author":"R Mistur","year":"2009","unstructured":"Mistur R et al. (2009) Current challenges for the early detection of Alzheimer\u2019s disease: brain imaging and CSF studies. J Clin Neurol 5(4):153\u2013166","journal-title":"J Clin Neurol"},{"key":"88_CR14","unstructured":"Guder WG, Nayaranan S, Wisser H, Zawta B (2014) Diagnostic samples: from the patient to the laboratory: the impact of preanalytical variables on the quality of laboratory results. Wiley"},{"key":"88_CR15","unstructured":"Banfi G, Deom A, Fr\u00e4ser CG, Hagemann P, Henny J, Kaliner A, Lepp\u00e4nen EA, Narayanan S, Neumaier M, Gomes MPA, Probst R (2009) Serum, plasma or whole blood? Which anticoagulants to use? Journal of Laboratory Medicine:297\u2013312"},{"issue":"6","key":"88_CR16","first-page":"629","volume":"67","author":"S Lehmann","year":"2009","unstructured":"Lehmann S et al. (2009) Preanalytical guidelines for clinical proteomics investigation of biological fluids. Ann Biol Clin (Paris) 67(6):629\u2013639","journal-title":"Ann Biol Clin (Paris)"},{"issue":"3","key":"88_CR17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","volume":"5","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5(3):492\u2013497","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"88_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4068\/cmj.2015.51.2.51","volume":"51","author":"YK Kim","year":"2015","unstructured":"Kim YK (2015) Extracellular microRNAs as biomarkers in human disease. Chonnam Med J 51(2):51\u201357","journal-title":"Chonnam Med J"},{"issue":"2","key":"88_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u2013233","journal-title":"Cell"},{"issue":"9","key":"88_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1101\/lm.026492.112","volume":"19","author":"W Wang","year":"2012","unstructured":"Wang W, Kwon EJ, Tsai LH (2012) MicroRNAs in learning, memory, and neurological diseases. Learn Mem 19(9):359\u2013368","journal-title":"Learn Mem"},{"issue":"7","key":"88_CR21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neurobiolaging.2010.08.017","volume":"32","author":"D Mastroeni","year":"2011","unstructured":"Mastroeni D et al. (2011) Epigenetic mechanisms in Alzheimer\u2019s disease. Neurobiol Aging 32(7):1161\u20131180","journal-title":"Neurobiol Aging"},{"issue":"4","key":"88_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neurobiolaging.2013.10.082","volume":"35","author":"DL Van den Hove","year":"2014","unstructured":"Van den Hove DL et al. (2014) Epigenetically regulated microRNAs in Alzheimer\u2019s disease. Neurobiol Aging 35(4):731\u2013745","journal-title":"Neurobiol Aging"},{"issue":"2","key":"88_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nbd.2012.02.016","volume":"46","author":"B Xu","year":"2012","unstructured":"Xu B et al. (2012) MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis 46(2):291\u2013301","journal-title":"Neurobiol Dis"},{"issue":"12","key":"88_CR24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nrn2726","volume":"10","author":"SM Eacker","year":"2009","unstructured":"Eacker SM, Dawson TM, Dawson VL (2009) Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 10(12):837\u2013841","journal-title":"Nat Rev Neurosci"},{"key":"88_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pnpbp.2015.02.003","volume":"64","author":"Y Dwivedi","year":"2016","unstructured":"Dwivedi Y (2016) Pathogenetic and therapeutic applications of microRNAs in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 64:341\u2013348","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"88_CR26","doi-asserted-by":"crossref","unstructured":"Cao DD, Li L, Chan WY (2016) MicroRNAs: key regulators in the central nervous system and their implication in neurological diseases. Int J Mol Sci 17(6)","DOI":"10.3390\/ijms17060842"},{"key":"88_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphys.2015.00040","volume":"6","author":"GD Femminella","year":"2015","unstructured":"Femminella GD, Ferrara N, Rengo G (2015) The emerging role of microRNAs in Alzheimer\u2019s disease. Front Physiol 6:40","journal-title":"Front Physiol"},{"issue":"3","key":"88_CR28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920209788185252","volume":"10","author":"OC Maes","year":"2009","unstructured":"Maes OC et al. (2009) MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr Genomics 10(3):154\u2013168","journal-title":"Curr Genomics"},{"issue":"2","key":"88_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nbd.2012.01.003","volume":"46","author":"C Delay","year":"2012","unstructured":"Delay C, Mandemakers W, Hebert SS (2012) MicroRNAs in Alzheimer\u2019s disease. Neurobiol Dis 46(2):285\u2013290","journal-title":"Neurobiol Dis"},{"key":"88_CR30","first-page":"51","volume":"6","author":"M Cosin-Tomas","year":"2014","unstructured":"Cosin-Tomas M et al. (2014) Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise. Front Aging Neurosci 6:51","journal-title":"Front Aging Neurosci"},{"key":"88_CR31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/1471-2164-15-644","volume":"15","author":"H Noh","year":"2014","unstructured":"Noh H et al. (2014) Prediction of miRNA-mRNA associations in Alzheimer\u2019s disease mice using network topology. BMC Genomics 15:644","journal-title":"BMC Genomics"},{"issue":"7","key":"88_CR32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.exger.2012.11.017","volume":"48","author":"S Weilner","year":"2013","unstructured":"Weilner S et al. (2013) Secretion of microvesicular miRNAs in cellular and organismal aging. Exp Gerontol 48(7):626\u2013633","journal-title":"Exp Gerontol"},{"issue":"9","key":"88_CR33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ncb1929","volume":"11","author":"DJ Gibbings","year":"2009","unstructured":"Gibbings DJ et al. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11(9):1143\u20131149","journal-title":"Nat Cell Biol"},{"issue":"5","key":"88_CR34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4161\/cib.3.5.12693","volume":"3","author":"H Iguchi","year":"2010","unstructured":"Iguchi H, Kosaka N, Ochiya T (2010) Secretory microRNAs as a versatile communication tool. Commun Integr Biol 3(5):478\u2013481","journal-title":"Commun Integr Biol"},{"issue":"3","key":"88_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","volume":"22","author":"X Chen","year":"2012","unstructured":"Chen X et al. (2012) Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22(3):125\u2013132","journal-title":"Trends Cell Biol"},{"key":"88_CR36","first-page":"24","volume":"6","author":"V Dorval","year":"2013","unstructured":"Dorval V, Nelson PT, Hebert SS (2013) Circulating microRNAs in Alzheimer\u2019s disease: the search for novel biomarkers. Front Mol Neurosci 6:24","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"88_CR37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.18632\/aging.100486","volume":"4","author":"KS Sheinerman","year":"2012","unstructured":"Sheinerman KS et al. (2012) Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) 4(9):590\u2013605","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"88_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130932","volume":"39","author":"T Kiko","year":"2014","unstructured":"Kiko T et al. (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer\u2019s disease. J Alzheimers Dis 39(2):253\u2013259","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"88_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan L et al. (2014) Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci 336(1\u20132):52\u201356","journal-title":"J Neurol Sci"},{"issue":"4","key":"88_CR40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan L et al. (2014) Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 40(4):1017\u20131027","journal-title":"J Alzheimers Dis"},{"key":"88_CR41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnmol.2014.00002","volume":"7","author":"S Bhatnagar","year":"2014","unstructured":"Bhatnagar S et al. (2014) Increased microRNA-34c abundance in Alzheimer\u2019s disease circulating blood plasma. Front Mol Neurosci 7:2","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"88_CR42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","volume":"235","author":"H Geekiyanage","year":"2012","unstructured":"Geekiyanage H et al. (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer\u2019s disease. Exp Neurol 235(2):491\u2013496","journal-title":"Exp Neurol"},{"issue":"7","key":"88_CR43","doi-asserted-by":"crossref","first-page":"e69807","DOI":"10.1371\/journal.pone.0069807","volume":"8","author":"P Kumar","year":"2013","unstructured":"Kumar P et al. (2013) Circulating miRNA biomarkers for Alzheimer\u2019s disease. PLoS One 8(7):e69807","journal-title":"PLoS One"},{"issue":"1","key":"88_CR44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/nmt.14.52","volume":"5","author":"LM Bekris","year":"2015","unstructured":"Bekris LM, Leverenz JB (2015) The biomarker and therapeutic potential of miRNA in Alzheimer\u2019s disease. Neurodegener Dis Manag 5(1):61\u201374","journal-title":"Neurodegener Dis Manag"},{"issue":"5","key":"88_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/1354750X.2013.814073","volume":"18","author":"LM Bekris","year":"2013","unstructured":"Bekris LM et al. (2013) MicroRNA in Alzheimer\u2019s disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers 18(5):455\u2013466","journal-title":"Biomarkers"},{"key":"88_CR46","first-page":"13","volume":"8","author":"YB Hu","year":"2016","unstructured":"Hu YB et al. (2016) Diagnostic value of microRNA for Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci 8:13","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"88_CR47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s12035-014-8944-x","volume":"52","author":"Y Zi","year":"2015","unstructured":"Zi Y et al. (2015) Circulating MicroRNA as potential source for neurodegenerative diseases biomarkers. Mol Neurobiol 52(3):1494\u20131503","journal-title":"Mol Neurobiol"},{"issue":"1","key":"88_CR48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12035-012-8359-5","volume":"47","author":"L Tan","year":"2013","unstructured":"Tan L, Yu JT, Hu N, Non-coding RNA (2013) In Alzheimer\u2019s disease. Mol Neurobiol 47(1):382\u2013393","journal-title":"Mol Neurobiol"},{"key":"88_CR49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-016-0053-5","volume":"5","author":"SS Sorensen","year":"2016","unstructured":"Sorensen SS, Nygaard AB, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia\u2014an exploratory study. Transl Neurodegener 5:6","journal-title":"Transl Neurodegener"},{"issue":"4","key":"88_CR50","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3233\/JAD-160038","volume":"52","author":"M Muller","year":"2016","unstructured":"Muller M et al. (2016) Validation of microRNAs in cerebrospinal fluid as biomarkers for different forms of dementia in a multicenter study. J Alzheimers Dis 52(4):1321\u20131333","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"88_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/1354750X.2014.904001","volume":"19","author":"PB Danborg","year":"2014","unstructured":"Danborg PB et al. (2014) The potential of microRNAs as biofluid markers of neurodegenerative diseases\u2014a systematic review. Biomarkers 19(4):259\u2013268","journal-title":"Biomarkers"},{"issue":"7","key":"88_CR52","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P et al. (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14(7):R78","journal-title":"Genome Biol"},{"key":"88_CR53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fncel.2013.00150","volume":"7","author":"KS Sheinerman","year":"2013","unstructured":"Sheinerman KS, Umansky SR (2013) Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7:150","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"88_CR54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.12236","volume":"18","author":"L Moldovan","year":"2014","unstructured":"Moldovan L et al. (2014) Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18(3):371\u2013390","journal-title":"J Cell Mol Med"},{"issue":"1","key":"88_CR55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","volume":"42","author":"D Alcolea","year":"2014","unstructured":"Alcolea D et al. (2014) Relationship between beta-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 42(1):157\u2013167","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"88_CR56","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","volume":"85","author":"D Alcolea","year":"2015","unstructured":"Alcolea D et al. (2015) Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology 85(7):626\u2013633","journal-title":"Neurology"},{"issue":"2","key":"88_CR57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00702-010-0534-0","volume":"118","author":"A Antonell","year":"2011","unstructured":"Antonell A et al. (2011) Different profiles of Alzheimer\u2019s disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints. J Neural Transm (Vienna) 118(2):259\u2013262","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"88_CR58","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/clinchem\/43.9.1657","volume":"43","author":"A Zivelin","year":"1997","unstructured":"Zivelin A et al. (1997) Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43(9):1657\u20131659","journal-title":"Clin Chem"},{"issue":"3","key":"88_CR59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ et al. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"88_CR60","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","volume":"50","author":"EM Kroh","year":"2010","unstructured":"Kroh EM et al. (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50(4):298\u2013301","journal-title":"Methods"},{"issue":"30","key":"88_CR61","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513\u201310518","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"88_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1373\/49.3.433","volume":"49","author":"C Stephan","year":"2003","unstructured":"Stephan C et al. (2003) Comparison of eight computer programs for receiver-operating characteristic analysis. Clin Chem 49(3):433\u2013439","journal-title":"Clin Chem"},{"issue":"1","key":"88_CR63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S1481803500013336","volume":"8","author":"J Fan","year":"2006","unstructured":"Fan J, Upadhye S, Worster A (2006) Understanding receiver operating characteristic (ROC) curves. CJEM 8(1):19\u201320","journal-title":"CJEM"},{"issue":"11","key":"88_CR64","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B et al. (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9(11):1118\u20131127","journal-title":"Lancet Neurol"},{"issue":"12","key":"88_CR65","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","volume":"28","author":"TT Rohn","year":"2008","unstructured":"Rohn TT et al. (2008) Lack of pathology in a triple transgenic mouse model of Alzheimer\u2019s disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 28(12):3051\u20133059","journal-title":"J Neurosci"},{"issue":"10","key":"88_CR66","doi-asserted-by":"crossref","first-page":"985","DOI":"10.18632\/aging.100371","volume":"3","author":"X Li","year":"2011","unstructured":"Li X et al. (2011) Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) 3(10):985\u20131002","journal-title":"Aging (Albany NY)"},{"issue":"4\u20135","key":"88_CR67","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.brainresbull.2009.08.006","volume":"80","author":"X Wang","year":"2009","unstructured":"Wang X et al. (2009) miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res Bull 80(4\u20135):268\u2013273","journal-title":"Brain Res Bull"},{"issue":"3","key":"88_CR68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2007-12303","volume":"12","author":"E Ferreiro","year":"2007","unstructured":"Ferreiro E et al. (2007) Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis 12(3):223\u2013228","journal-title":"J Alzheimers Dis"},{"key":"88_CR69","doi-asserted-by":"crossref","first-page":"731479","DOI":"10.1155\/2015\/731479","volume":"2015","author":"P Tiberio","year":"2015","unstructured":"Tiberio P et al. (2015) Challenges in using circulating miRNAs as cancer biomarkers. Biomed Res Int 2015:731479","journal-title":"Biomed Res Int"},{"issue":"6","key":"88_CR70","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald JS et al. (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57(6):833\u2013840","journal-title":"Clin Chem"},{"issue":"7","key":"88_CR71","doi-asserted-by":"crossref","first-page":"e41561","DOI":"10.1371\/journal.pone.0041561","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang K et al. (2012) Comparing the MicroRNA spectrum between serum and plasma. PLoS One 7(7):e41561","journal-title":"PLoS One"},{"issue":"6","key":"88_CR72","doi-asserted-by":"crossref","first-page":"e64795","DOI":"10.1371\/journal.pone.0064795","volume":"8","author":"HH Cheng","year":"2013","unstructured":"Cheng HH et al. (2013) Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 8(6):e64795","journal-title":"PLoS One"},{"issue":"1","key":"88_CR73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"JP Cogswell","year":"2008","unstructured":"Cogswell JP et al. (2008) Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14(1):27\u201341","journal-title":"J Alzheimers Dis"},{"key":"88_CR74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","volume":"1646","author":"S Sarkar","year":"2016","unstructured":"Sarkar S et al. (2016) Expression of microRNA-34a in Alzheimer\u2019s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139\u2013151","journal-title":"Brain Res"},{"issue":"36","key":"88_CR75","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","volume":"105","author":"M Yamakuchi","year":"2008","unstructured":"Yamakuchi M, Ferlito M, Lowenstein CJ (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 105(36):13421\u201313426","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"88_CR76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","volume":"68","author":"C Julien","year":"2009","unstructured":"Julien C et al. (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68(1):48\u201358","journal-title":"J Neuropathol Exp Neurol"},{"key":"88_CR77","first-page":"64","volume":"9","author":"F Ng","year":"2015","unstructured":"Ng F, Wijaya L, Tang BL (2015) SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci 9:64","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"88_CR78","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.neuroscience.2008.04.065","volume":"154","author":"M Pallas","year":"2008","unstructured":"Pallas M et al. (2008) Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 154(4):1388\u20131397","journal-title":"Neuroscience"},{"issue":"4","key":"88_CR79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2011-101908","volume":"24","author":"K Kaarniranta","year":"2011","unstructured":"Kaarniranta K et al. (2011) Age-related macular degeneration (AMD): Alzheimer\u2019s disease in the eye? J Alzheimers Dis 24(4):615\u2013631","journal-title":"J Alzheimers Dis"},{"key":"88_CR80","first-page":"232","volume":"6","author":"JM Hill","year":"2015","unstructured":"Hill JM, Pogue AI, Lukiw WJ (2015) Pathogenic microRNAs common to brain and retinal degeneration; recent observations in Alzheimer\u2019s disease and age-related macular degeneration. Front Neurol 6:232","journal-title":"Front Neurol"},{"issue":"Database issue","key":"88_CR81","doi-asserted-by":"crossref","first-page":"D78","DOI":"10.1093\/nar\/gkt1266","volume":"42","author":"SD Hsu","year":"2014","unstructured":"Hsu SD et al. (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 42(Database issue):D78\u2013D85","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"88_CR82","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1517\/14728222.2013.789862","volume":"17","author":"H Martiskainen","year":"2013","unstructured":"Martiskainen H et al. (2013) Targeting ApoE4\/ApoE receptor LRP1 in Alzheimer\u2019s disease. Expert Opin Ther Targets 17(7):781\u2013794","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"88_CR83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue JE et al. (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathol 112(4):405\u2013415","journal-title":"Acta Neuropathol"},{"issue":"8","key":"88_CR84","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","volume":"56","author":"CI Sze","year":"1997","unstructured":"Sze CI et al. (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56(8):933\u2013944","journal-title":"J Neuropathol Exp Neurol"},{"key":"88_CR85","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1038\/srep07130","volume":"4","author":"D Yuki","year":"2014","unstructured":"Yuki D et al. (2014) DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer\u2019s disease. Sci Rep 4:7130","journal-title":"Sci Rep"},{"issue":"43","key":"88_CR86","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1073\/pnas.0507666102","volume":"102","author":"SJ Glatt","year":"2005","unstructured":"Glatt SJ et al. (2005) Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A 102(43):15533\u201315538","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"88_CR87","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7150\/ijms.8647","volume":"11","author":"X Ma","year":"2014","unstructured":"Ma X et al. (2014) Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 11(8):810\u2013818","journal-title":"Int J Med Sci"},{"issue":"5","key":"88_CR88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jalz.2012.08.004","volume":"9","author":"AC Harten van","year":"2013","unstructured":"van Harten AC et al. (2013) Cerebrospinal fluid Abeta42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dement 9(5):481\u2013487","journal-title":"Alzheimers Dement"},{"issue":"1","key":"88_CR89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-140075","volume":"47","author":"AC Harten van","year":"2015","unstructured":"van Harten AC et al. (2015) Differential expression of microRNA in cerebrospinal fluid as a potential novel biomarker for Alzheimer\u2019s disease. J Alzheimers Dis 47(1):243\u2013252","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"88_CR90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-2009-0999","volume":"16","author":"MI Kester","year":"2009","unstructured":"Kester MI et al. (2009) CSF biomarkers in Alzheimer\u2019s disease and controls: associations with APOE genotype are modified by age. J Alzheimers Dis 16(3):601\u2013607","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"88_CR91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","volume":"29","author":"C Humpel","year":"2011","unstructured":"Humpel C (2011) Identifying and validating biomarkers for Alzheimer\u2019s disease. Trends Biotechnol 29(1):26\u201332","journal-title":"Trends Biotechnol"},{"issue":"2","key":"88_CR92","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.juro.2006.09.063","volume":"177","author":"JW Moul","year":"2007","unstructured":"Moul JW et al. (2007) Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol 177(2):499\u2013503 discussion 503\u20134","journal-title":"J Urol"},{"key":"88_CR93","doi-asserted-by":"crossref","unstructured":"Hollins SL, Cairns MJ (2016) MicroRNA: small RNA mediators of the brains genomic response to environmental stress. Prog Neurobiol 143:61\u201381","DOI":"10.1016\/j.pneurobio.2016.06.005"},{"key":"88_CR94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neubiorev.2015.10.010","volume":"60","author":"JF Codocedo","year":"2016","unstructured":"Codocedo JF, Inestrosa NC (2016) Environmental control of microRNAs in the nervous system: implications in plasticity and behavior. Neurosci Biobehav Rev 60:121\u2013138","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"88_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.00095.2014","volume":"47","author":"E Flowers","year":"2015","unstructured":"Flowers E, Won GY, Fukuoka Y (2015) MicroRNAs associated with exercise and diet: a systematic review. Physiol Genomics 47(1):1\u201311","journal-title":"Physiol Genomics"},{"issue":"2","key":"88_CR96","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/sms.12421","volume":"25","author":"T Xu","year":"2015","unstructured":"Xu T et al. (2015) Circulating microRNAs in response to exercise. Scand J Med Sci Sports 25(2):e149\u2013e154","journal-title":"Scand J Med Sci Sports"},{"key":"88_CR97","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fphys.2013.00266","volume":"4","author":"E Zacharewicz","year":"2013","unstructured":"Zacharewicz E, Lamon S, Russell AP (2013) MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease. Front Physiol 4:266","journal-title":"Front Physiol"},{"key":"88_CR98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.arr.2014.04.005","volume":"17","author":"JD Palmer","year":"2014","unstructured":"Palmer JD et al. (2014) MicroRNA expression altered by diet: can food be medicinal? Ageing Res Rev 17:16\u201324","journal-title":"Ageing Res Rev"},{"issue":"1","key":"88_CR99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","volume":"8","author":"H Vanderstichele","year":"2012","unstructured":"Vanderstichele H et al. (2012) Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s biomarkers standardization initiative. Alzheimers Dement 8(1):65\u201373","journal-title":"Alzheimers Dement"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0088-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:13:49Z","timestamp":1601054029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0088-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0088-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]}}}